Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course Ripasudil vs placebo after selective laser trabeculoplasty
TCTR20250606004Phase 2Recruiting
- Sponsor
- Research and Innovation Fund, Prince of Songkla University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ripasudil in Glaucoma, sponsored by Research and Innovation Fund, Prince of Songkla University. Started Sep 2025; status: recruiting.
02
Drugs
ripasudil
03
Conditions
Glaucoma
Beyond the preview
Go deeper on TCTR20250606004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250606004.